| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 59-71, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Dellian, BP Witwer, HA Salehi, F Yuan and RK Jain
E.L. Steele Laboratory, Department of Radiation Oncology, MassachusettsGeneral Hospital, Boston, USA.
A prerequisite for the development of novel angiogenic and anti- angiogenic agents is the availability of routine in vivo assays that permit 1) repeated, long-term quantitation of angiogenesis and 2) physiological characterization of angiogenic vessels. We report here the development of such an assay in mice. Using this assay, we tested the hypothesis that the physiological properties of angiogenic vessels governed by the microenvironment and vessel origin rather than the initial angiogenic stimulus. Gels containing basic fibroblast growth factor (bFGF) or vascular endothelial growth (VEGF) were implanted in transparent windows in the dorsal skin or cranium of mice. Vessels could be continuously and non-invasively monitored and easily quantified for more than 5 weeks after gel implantation. Newly formed vessels were first visible on day 4 in the cranial window and day 10 in the dorsal skinfold chamber, respectively. The number of vessels was dependent on the dose of bFGF and VEGF. At 3000 ng/ml, bFGF- and VEGF- induced blood vessels had similar diameters, red blood cell velocities, and microvascular permeability to albumin. However, red blood cell velocities and microvascular permeability to albumin were higher in the cranial window than in the dorsal skinfold chamber. Leukocyte- endothelial interaction was nearly zero in both sites. Thus, newly grown microvessels resembled vessels of granulation and neoplastic tissue in many aspects. Their physiological properties were mainly determined by the microenvironment, whereas the initial angiogenic response was stimulated by growth factors.
This article has been cited by other articles:
 |
|
 |
|
  P. Hoffmann, J.-J. Feige, and N. Alfaidy Expression and Oxygen Regulation of Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 and Its Receptors in Human Placenta during Early Pregnancy Endocrinology, April 1, 2006; 147(4): 1675 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Kruskal, P. Thomas, R. A. Kane, and S. N. Goldberg Hepatic Perfusion Changes in Mice Livers with Developing Colorectal Cancer Metastases Radiology, May 1, 2004; 231(2): 482 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Xaymardan, J. Zheng, I. Duignan, A. Chin, J. M. Holm, V. L.T. Ballard, and J. M. Edelberg Senescent Impairment in Synergistic Cytokine Pathways That Provide Rapid Cardioprotection in the Rat Heart J. Exp. Med., March 15, 2004; 199(6): 797 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Peirce, R. J. Price, and T. C. Skalak Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1 Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H918 - H925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C.L. Schuh Trials, Tribulations, and Trends in Tumor Modeling in Mice Toxicol Pathol, January 1, 2004; 32(1_suppl): 53 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 J. LeCouter, R. Lin, M. Tejada, G. Frantz, F. Peale, K. J. Hillan, and N. Ferrara The endocrine-gland-derived VEGF homologue Bv8 promotes angiogenesis in the testis: Localization of Bv8 receptors to endothelial cells PNAS, March 4, 2003; 100(5): 2685 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, N. Yang, J.-R. Conejo-Garcia, D. Katsaros, A. Mohamed-Hadley, S. Fracchioli, K. Schlienger, A. Toll, B. Levine, S. C. Rubin, et al. Expression of Endocrine Gland-derived Vascular Endothelial Growth Factor in Ovarian Carcinoma Clin. Cancer Res., January 1, 2003; 9(1): 264 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Monsky, C. M. Carreira, Y. Tsuzuki, T. Gohongi, D. Fukumura, and R. K. Jain Role of Host Microenvironment in Angiogenesis and Microvascular Functions in Human Breast Cancer Xenografts: Mammary Fat Pad versus Cranial Tumors Clin. Cancer Res., April 1, 2002; 8(4): 1008 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lin, J. LeCouter, J. Kowalski, and N. Ferrara Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells J. Biol. Chem., March 1, 2002; 277(10): 8724 - 8729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fukumura, T. Gohongi, A. Kadambi, Y. Izumi, J. Ang, C.-O. Yun, D. G. Buerk, P. L. Huang, and R. K. Jain Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability PNAS, February 27, 2001; 98(5): 2604 - 2609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Miller, C. J. Sweeney, and G. W. Sledge Jr Redefining the Target: Chemotherapeutics as Antiangiogenics J. Clin. Oncol., February 15, 2001; 19(4): 1195 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sato, R. J. Laham, J. D. Pearlman, D. Novicki, F. W. Sellke, M. Simons, and M. J. Post Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia Ann. Thorac. Surg., December 1, 2000; 70(6): 2113 - 2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tsuzuki, D. Fukumura, B. Oosthuyse, C. Koike, P. Carmeliet, and R. K. Jain Vascular Endothelial Growth Factor (VEGF) Modulation by Targeting Hypoxia-inducible Factor-1{{alpha}} {->} Hypoxia Response Element {->} VEGF Cascade Differentially Regulates Vascular Response and Growth Rate in Tumors Cancer Res., November 1, 2000; 60(22): 6248 - 6252. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. C. Tromp, M. G. A. oude Egbrink, R. P. M. Dings, S. van Velzen, D. W. Slaaf, H. F. P. Hillen, G. J. Tangelder, R. S. Reneman, and A. W. Griffioen Tumor angiogenesis factors reduce leukocyte adhesion in vivo Int. Immunol., May 1, 2000; 12(5): 671 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Parsons-Wingerter, K. E. Elliott, J. I. Clark, and A. G. Farr Fibroblast Growth Factor-2 Selectively Stimulates Angiogenesis of Small Vessels in Arterial Tree Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1250 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Hartford, T. Gohongi, D. Fukumura, and R. K. Jain Irradiation of a Primary Tumor, Unlike Surgical Removal, Enhances Angiogenesis Suppression at a Distal Site: Potential Role of Host-Tumor Interaction Cancer Res., April 1, 2000; 60(8): 2128 - 2131. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. C. Drummond, O. Meyer, K. Hong, D. B. Kirpotin, and D. Papahadjopoulos Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors Pharmacol. Rev., December 1, 1999; 51(4): 691 - 744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Roberts, J. Delaat, M. Nagane, S. Huang, W. K. Cavenee, and G. E. Palade Host Microvasculature Influence on Tumor Vascular Morphology and Endothelial Gene Expression Am. J. Pathol., October 1, 1998; 153(4): 1239 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ozaki, N. Okamoto, S. Ortega, M. Chang, K. Ozaki, S. Sadda, M. A. Vinores, N. Derevjanik, D. J. Zack, C. Basilico, et al. Basic Fibroblast Growth Factor Is Neither Necessary nor Sufficient for the Development of Retinal Neovascularization Am. J. Pathol., September 1, 1998; 153(3): 757 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Carmeliet, L. Moons, and D. Collen Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis Cardiovasc Res, July 1, 1998; 39(1): 8 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment PNAS, April 14, 1998; 95(8): 4607 - 4612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Murohara, J. R. Horowitz, M. Silver, Y. Tsurumi, D. Chen, A. Sullivan, and J. M. Isner Vascular Endothelial Growth Factor/Vascular Permeability Factor Enhances Vascular Permeability Via Nitric Oxide and Prostacyclin Circulation, January 13, 1998; 97(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrara and T. Davis-Smyth The Biology of Vascular Endothelial Growth Factor Endocr. Rev., February 1, 1997; 18(1): 4 - 25. [Abstract] [Full Text]
|
|
|
|
|
|
F. Yuan, Y. Chen, M. Dellian, N. Safabakhsh, N. Ferrara, and R. K. Jain Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody PNAS, December 10, 1996; 93(25): 14765 - 14770. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
